Todd K. Rosengart

Therapeutic Angiogenesis: Protein and Gene Therapy Delivery Strategies

T. Rosengart, R. Crystal, Shailen R. Patel, 1999, Journal of cardiovascular risk.

Therapeutic angiogenesis: a comparative study of the angiogenic potential of acidic fibroblast growth factor and heparin.

T. Rosengart, O. Isom, C. Mack, 1997, Journal of vascular surgery.

Use of quantitative TaqMan real-time PCR to track the time-dependent distribution of gene transfer vectors in vivo.

R. Crystal, J. O’Leary, N. Hackett, 2000, Molecular therapy : the journal of the American Society of Gene Therapy.

Regional angiogenesis induced in nonischemic tissue by an adenoviral vector expressing vascular endothelial growth factor.

R. Crystal, T. Rosengart, O. Isom, 1997, Human gene therapy.

Direct in vivo gene transfer to canine myocardium using a replication-deficient adenovirus vector.

R. Crystal, R. Hahn, T. Rosengart, 1996, The Annals of thoracic surgery.

Circumvention of anti-adenovirus neutralizing immunity by administration of an adenoviral vector of an alternate serotype.

R. Crystal, N. Hackett, B. Harvey, 1997, Human gene therapy.

Transmyocardial laser revascularization and angiogenesis: the potential for therapeutic benefit.

T. Rosengart, L. Lee, Leonard Y. Lee, 1999, Seminars in thoracic and cardiovascular surgery.

Repair of atrial septal defect through a right thoracotomy.

J. Stark, T. Rosengart, Todd K. Rosengart, 1993, The Annals of thoracic surgery.

Homozygous deletion of early growth response 1 gene and critical limb ischemia after vascular ligation in mice: evidence for a central role in vascular homeostasis.

R. Crystal, J. Milbrandt, M. Retuerto, 2004, The Journal of thoracic and cardiovascular surgery.